INSPIRE MEDICAL SYSTEMS INC (INSP)

US4577301090 - Common Stock

187.77  +2.35 (+1.27%)

Premarket: 180.45 -7.32 (-3.9%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
233.4M
102.25%
407.9M
74.76%
624.799M
53.17%
812.01M
29.96%
970.55M
19.52%
1.144B
17.87%
1.336B
16.78%
1.539B
15.19%
1.737B
12.87%
1.962B
12.95%
2.104B
7.24%
EBITDA
YoY % growth
-38.68M
30.13%
-45.74M
-18.25%
-37.425M
18.18%
1.448M
103.87%
62.535M
4,218.72%
114.67M
83.37%
277.34M
141.86%
342.21M
23.39%
407.29M
19.02%
479.5M
17.73%
564.47M
17.72%
EBIT
YoY % growth
-39.9M
29.00%
-47.6M
-19.30%
-40.271M
15.40%
20.701M
151.40%
49.72M
140.18%
96.934M
94.96%
162.15M
67.28%
218.31M
34.63%
303.01M
38.80%
368.36M
21.57%
447.07M
21.37%
Operating Margin
-17.10%-11.67%-6.45%2.55%5.12%8.47%12.14%14.19%17.44%18.77%21.25%
EPS
YoY % growth
-1.55
30.18%
-1.64
-5.81%
-0.74
54.88%
1.35
282.55%
2.04
50.66%
3.24
59.36%
3.90
20.21%
5.42
38.91%
7.09
30.95%
8.90
25.50%
8.48
-4.78%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.73
49.64%
-0.11
67.86%
0.44
38.43%
0.58
-3.71%
1.05
43.60%
0.49
548.01%
0.57
28.95%
0.61
5.93%
0.69
-34.13%
Revenue
Q2Q % growth
237.95M
23.61%
203.75M
24.23%
236.82M
20.90%
244.24M
20.20%
283.8M
19.27%
248.3M
21.87%
281.43M
18.84%
287.67M
17.78%
314.15M
10.69%
EBITDA
Q2Q % growth
26.207M
115.82%
-6.408M
55.44%
15.049M
105.56%
21.222M
15.40%
39.355M
50.17%
8.69M
235.62%
12.413M
-17.52%
14.647M
-30.98%
16.85M
-57.18%
EBIT
Q2Q % growth
18.596M
100.02%
-8.912M
41.44%
9.397M
84.29%
14.79M
3.30%
29.727M
59.86%
6.701M
175.19%
9.282M
-1.22%
10.934M
-26.07%
13.505M
-54.57%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
0.60
306.90%
0.080.52681.29%
Q2 2024
Q2Q % growth
0.32
178.05%
-0.140.46325.04%
Q1 2024
Q2Q % growth
-0.34
35.85%
-0.660.3248.86%
Q4 2023
Q2Q % growth
0.49
390.00%
-0.090.58642.33%
Q3 2023
Q2Q % growth
-0.29
51.67%
-0.590.3051.01%
Q2 2023
Q2Q % growth
-0.41
22.64%
-0.580.1729.39%
Q1 2023
Q2Q % growth
-0.53
13.11%
-0.670.1421.27%
Q4 2022
Q2Q % growth
0.10
211.11%
-0.580.68117.32%
Q3 2022
Q2Q % growth
-0.60
-57.89%
-0.780.1823.21%
Q2 2022
Q2Q % growth
-0.53
-10.42%
-0.630.1015.95%
Q1 2022
Q2Q % growth
-0.61
-1.67%
-0.810.2024.87%
Q4 2021
Q2Q % growth
-0.09
67.86%
-0.450.3679.81%
Q3 2021
Q2Q % growth
-0.38
2.56%
-0.630.2539.38%
Q2 2021
Q2Q % growth
-0.48
45.45%
-0.650.1726.57%
Q1 2021
Q2Q % growth
-0.60
10.45%
-0.670.0710.87%
Q4 2020
Q2Q % growth
-0.28
26.32%
-0.490.2143.08%
Q3 2020
Q2Q % growth
-0.39
-14.71%
-0.740.3547.01%
Q2 2020
Q2Q % growth
-0.88
-175.00%
-1.120.2421.57%
Q1 2020
Q2Q % growth
-0.67
-91.43%
-0.58-0.09-15.89%
Q4 2019
Q2Q % growth
-0.38
-72.73%
-0.410.037.21%
Q3 2019
Q2Q % growth
-0.34
-54.55%
-0.420.0819.26%
Q2 2019
Q2Q % growth
-0.32
25.58%
-0.440.1227.62%
Q1 2019
Q2Q % growth
-0.35
93.07%
-0.390.049.97%
Q4 2018
Q2Q % growth
-0.22 -0.320.1031.06%
Q3 2018
Q2Q % growth
-0.22 -0.350.1338.02%
Q2 2018
Q2Q % growth
-0.43 -0.520.0917.74%
Q1 2018
Q2Q % growth
-5.05 -3.71-1.34-36.02%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
203.191M
32.54%
201.55M1.641M0.81%
Q2 2024
Q2Q % growth
195.885M
29.65%
193.25M2.635M1.36%
Q1 2024
Q2Q % growth
164.01M
28.24%
164.67M-660K-0.40%
Q4 2023
Q2Q % growth
192.508M
39.60%
190.98M1.528M0.80%
Q3 2023
Q2Q % growth
153.302M
40.39%
157.54M-4.238M-2.69%
Q2 2023
Q2Q % growth
151.092M
65.31%
139.07M12.022M8.64%
Q1 2023
Q2Q % growth
127.897M
84.29%
121.69M6.207M5.10%
Q4 2022
Q2Q % growth
137.9M
75.89%
131.85M6.05M4.59%
Q3 2022
Q2Q % growth
109.2M
76.99%
96.201M12.999M13.51%
Q2 2022
Q2Q % growth
91.4M
72.45%
79.841M11.559M14.48%
Q1 2022
Q2Q % growth
69.4M
71.78%
65.454M3.946M6.03%
Q4 2021
Q2Q % growth
78.4M
70.43%
78.117M283K0.36%
Q3 2021
Q2Q % growth
61.7M
72.35%
56.725M4.975M8.77%
Q2 2021
Q2Q % growth
53M
334.43%
44.747M8.253M18.44%
Q1 2021
Q2Q % growth
40.4M
89.67%
37.678M2.722M7.22%
Q4 2020
Q2Q % growth
46M
71.00%
41.895M4.105M9.80%
Q3 2020
Q2Q % growth
35.8M
71.29%
23.203M12.597M54.29%
Q2 2020
Q2Q % growth
12.2M
-32.22%
8.009M4.191M52.33%
Q1 2020
Q2Q % growth
21.3M
30.67%
21.688M-388K-1.79%
Q4 2019
Q2Q % growth
26.9M
62.05%
24.32M2.58M10.61%
Q3 2019
Q2Q % growth
20.9M
59.54%
19.561M1.339M6.85%
Q2 2019
Q2Q % growth
18M
65.14%
17.008M992K5.83%
Q1 2019
Q2Q % growth
16.3M
63.00%
15.294M1.006M6.58%
Q4 2018
Q2Q % growth
16.6M 14.353M2.247M15.66%
Q3 2018
Q2Q % growth
13.1M 10.847M2.253M20.77%
Q2 2018
Q2Q % growth
10.9M 9.734M1.166M11.98%
Q1 2018
Q2Q % growth
10M 10.169M-169K-1.66%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 13.68% 0% 78.26%
Revenue0% -3.04% 0% 0.12%